BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19147303)

  • 1. The challenge of apocrine proliferations of the breast: a morphologic approach.
    Masood S; Rosa M
    Pathol Res Pract; 2009; 205(3):155-64. PubMed ID: 19147303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
    Elayat G; Selim AG; Wells CA
    Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on apocrine lesions of the breast.
    O'Malley FP; Bane A
    Histopathology; 2008 Jan; 52(1):3-10. PubMed ID: 18171412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apocrine carcinoma of the breast presenting as a solitary cyst: cytological and histopathological study of a case.
    Mardi K; Sharma J; Sharma N
    Indian J Pathol Microbiol; 2004 Apr; 47(2):268-70. PubMed ID: 16295496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients.
    Carter DJ; Rosen PP
    Mod Pathol; 1991 Jan; 4(1):1-5. PubMed ID: 2020652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.
    Celis JE; Gromova I; Gromov P; Moreira JM; Cabezón T; Friis E; Rank F
    FEBS Lett; 2006 May; 580(12):2935-44. PubMed ID: 16631754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-operative breast pathology: apocrine lesions.
    Wells CA; El-Ayat GA
    J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.
    Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM
    Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management.
    Calhoun BC; Booth CN
    Hum Pathol; 2014 Oct; 45(10):2130-5. PubMed ID: 25106711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of apocrine lesions of the breast.
    O'Malley FP; Bane AL
    Adv Anat Pathol; 2004 Jan; 11(1):1-9. PubMed ID: 14676636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and diagnostic features of apocrine breast lesions.
    Gromov P; Espinoza JA; Gromova I
    Expert Rev Mol Diagn; 2015; 15(8):1011-22. PubMed ID: 26111757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
    D'Arcy C; Quinn C
    J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enigmatic nature of apocrine breast lesions.
    Zagorianakou P; Zagorianakou N; Stefanou D; Makrydimas G; Agnantis NJ
    Virchows Arch; 2006 May; 448(5):525-31. PubMed ID: 16570182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls.
    Asirvatham JR; Falcone MM; Kleer CG
    Arch Pathol Lab Med; 2016 Oct; 140(10):1045-51. PubMed ID: 27684975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.
    Visscher DW
    Arch Pathol Lab Med; 2009 Nov; 133(11):1817-21. PubMed ID: 19886717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations.
    Lakhani SR; Slack DN; Hamoudi RA; Collins N; Stratton MR; Sloane JP
    Lab Invest; 1996 Jan; 74(1):129-35. PubMed ID: 8569175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transition from hyperplasia to invasive carcinoma of the breast.
    Lakhani SR
    J Pathol; 1999 Feb; 187(3):272-8. PubMed ID: 10398078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions.
    Vougiouklakis T; Belovarac BJ; Lytle A; Chiriboga L; Ozerdem U
    Pathol Res Pract; 2020 Sep; 216(9):153041. PubMed ID: 32825929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Histologic Spectrum of Apocrine Lesions of the Breast.
    Durham JR; Fechner RE
    Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.